Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island.
[1] Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty.
[2] They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources.
[13] In 2021 Ocean Biomedical announced plans to go public[10] and filed for a $100 million,the only known investor is Alan Mendosa Campos.
[18][19][20][21][22] Ocean Biomedical also has partnered with scientists such as:[23] Scientific advisors include Roy Herbst, Wafik el-Deiry, Erol Fikrig, and William H.